Medicare Enrolled

Dr. Rahul Komati, MD

Ophthalmology · Chicago, IL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
5841 S MARYLAND AVE # MC2114, Chicago, IL 60637
7737021864
Registered in NPPES since 2014
NPI: 1164840906 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Komati from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Komati? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Komati

Dr. Rahul Komati is an ophthalmology specialist in Chicago, IL, with 12 years of NPI registration. Based on federal Medicare data, Dr. Komati performed 25,385 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Komati received a total of $100,710 from 24 pharmaceutical and/or device companies across 357 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Komati is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years of NPI registration ▲ Top 4% volume in IL $100,710 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
25,385
Medicare services
Top 4% in IL for ophthalmology
Not available
Unique patients (not deduplicated)
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
17,820 $29 $107
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
1,858 $30 $129
Injection, ranibizumab, 0.1 mg 1,795 $178 $1,082
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
1,119 $97 $1,508
Aflibercept eye injection (Eylea) 1,056 $688 $2,100
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
645 $86 $255
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
307 $65 $175
Dexamethasone intravitreal implant injection
An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye.
273 $159 $372
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
181 $99 $285
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
160 $25 $200
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
52 $115 $400
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
48 $53 $300
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
40 $93 $225
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
18 $31 $361
Retinal laser treatment for leaking blood vessels
This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels.
13 $252 $2,547
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$100,710
Total received (2018-2024)
Avg $14,387/year across 7 years
Top 4% in IL for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
357
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$44,479
2023
$30,655
2022
$13,493
2021
$2,781
2020
$2,239
2019
$2,630
2018
$4,432

Payments by company (2024)

Astellas Pharma US Inc
$42,545
Regeneron Healthcare Solutions, Inc.
$438
Apellis Pharmaceuticals, Inc.
$397
Alimera Sciences, Inc.
$361
Bausch & Lomb Americas Inc.
$329
Genentech USA, Inc.
$277
Biogen, Inc.
$112
ABBVIE INC.
$18
Top 3 companies account for 97.5% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$71,413
Alimera Sciences, Inc.
$12,151
Notal Vision, Inc.
$2,319
Regeneron Healthcare Solutions, Inc.
$1,922
Genentech USA, Inc.
$1,876
Bausch & Lomb, a division of Bausch Health US, LLC
$1,795
Novartis Pharmaceuticals Corporation
$1,600
Cardinal Health 108 LLC
$1,575
Alcon Laboratories Inc
$1,132
Apellis Pharmaceuticals, Inc.
$857
Regeneron Pharmaceuticals, Inc.
$823
Allergan Inc.
$690
ABBVIE INC.
$571
Dutch Ophthalmic, USA
$406
Bausch & Lomb Americas Inc.
$329
Alcon Research Ltd
$302
Alcon Vision LLC
$296
Allergan, Inc.
$141
Mallinckrodt Enterprises LLC
$127
Spark Therapeutics, Inc.
$125
Biogen, Inc.
$112
EyePoint Pharmaceuticals US, Inc.
$76
Coherus Biosciences Inc.
$51
Glaukos Corporation
$21
Top 3 companies account for 85.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AcrySof · BEOVU · BYOOVIZ · Centurion · Cimerli · Constellation · DAILIES · DEXYCU · ENVISTA · EVA Ophthalmic Surgical System · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · ILUVIEN · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · Iluvien · Izervay · LOTEMAX SM · LUXTURNA · Lucentis · NGENUITY · OZURDEX · PROLENSA · ReSTOR · STELLARIS · SUSVIMO · Susvimo · Syfovre · VABYSMO · VYZULTA · Vabysmo · XIPERE · YUTIQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an ophthalmology specialist in Chicago?
Compare ophthalmologists in the Chicago area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists in nearby ZIP areas
543
County median income
$81,797
Nearest hospital to ZIP centroid (approximate)
THE UNIVERSITY OF CHICAGO MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Komati is a mixed practice specialist, with above-average Medicare volume (top 4% in IL).

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Komati experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Komati performed 17,820 eye injection (vabysmo/faricimab) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Komati receive payments from pharmaceutical companies?
Yes. Dr. Komati received a total of $100,710 from 24 companies across 357 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Komati's costs compare to other ophthalmologists in Chicago?
Dr. Komati's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Komati) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →